Clinical Trial Update: Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) [Phase 3]

View source ↗

Summary

Phase 3 rollover studies of Zerit (stavudine) extended-release formulations have completed, reporting results in HIV infection and AIDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Zerit (stavudine) ER (stavudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections, AIDS | Phase 3 | Status: COMPLETED